Massimo Breccia (M Breccia)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 138

Top Venues

British journal of haematology

American journal of hematology

Leukemia

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Sílvia Marcé, Aleix Méndez, Blanca Xicoy Cirici, Natalia Estrada, Marta Cabezón, Antonella Luciana Sturla, Miriam Ratia García, Anna Angona, Paula Amat, Silvia Escribano-Serrat, Emilia Scalzulli, Mireia Morgades, Alicia Senín, Juan Carlos Carlos Hernández-Boluda, Francisca Ferrer-Marín, Eduardo Anguita, Montserrat Cortés, Esther Plensa, Massimo Breccia, J Valentín García-Gutiérrez, Lurdes Zamora, null null
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response. Journal of clinical medicine 13 (3) (2024)
Saveria Capria, Silvia Maria Trisolini, Lorenzo Torrieri, Elena Amabile, Giovanni Marsili, Alfonso Piciocchi, Walter Barberi, Anna Paola Iori, Daniela Diverio, Daniela Carmini, Massimo Breccia, Maurizio Martelli, Clara Minotti
Real-Life Management of FLT3-Mutated AML: Single-Centre Experience over 24 Years. Cancers 16 (16) (2024)
Camille Kockerols, Peter J M Valk, Stephanie Dulucq, Franck-Emmanuel Nicolini, François-Xavier Mahon, Ehab Atallah, Michael J Mauro, Jerald P Radich, Simona Bernardi, Domenico Russo, Mirko Farina, Silvia Mori, Carlo B Gambacorti-Passerini, Ivan Civettini, Liu Lu, David Yeung, Susan Branford, Gioia Colafigli, Massimo Breccia, Pauline Hogenbirk, Joost van Rosmalen, Jan J Cornelissen, Peter E Westerweel
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis. American journal of hematology 99 (8) (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Camille Kockerols, Peter J M Valk, Stephanie Dulucq, Franck-Emmanuel Nicolini, François-Xavier Mahon, Ehab Atallah, Michael J Mauro, Jerald P Radich, Simona Bernardi, Domenico Russo, Mirko Farina, Silvia Mori, Carlo B Gambacorti-Passerini, Ivan Civettini, Liu Lu, David Yeung, Susan Branford, Gioia Colafigli, Massimo Breccia, Pauline Hogenbirk, Joost van Rosmalen, Jan J Cornelissen, Peter E Westerweel
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis. American journal of hematology (2024)
Alessandro Costa, Elisabetta Abruzzese, Roberto Latagliata, Olga Mulas, Ida Carmosino, Emilia Scalzulli, Maria Laura Bisegna, Claudia Ielo, Maurizio Martelli, Giovanni Caocci, Massimo Breccia
Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia. Journal of clinical medicine 13 (1) (2024)
Alessandro Laganà, Mauro Passucci, Sara Pepe, Emilia Scalzulli, Ida Carmosino, Alessandro Costa, Maria Laura Bisegna, Claudia Ielo, Maurizio Martelli, Massimo Breccia
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation. European journal of haematology (2024)
Ilaria Crespiatico, Mattia Zaghi, Cristina Mastini, Deborah D'Aliberti, Mario Mauri, Carl Mirko Mercado, Diletta Fontana, Silvia Spinelli, Valentina Crippa, Elena Inzoli, Beatrice Manghisi, Ivan Civettini, Daniele Ramazzotti, Valentina Sangiorgio, Michele Gengotti, Virginia Brambilla, Andrea Aroldi, Federica Banfi, Cristiana Barone, Roberto Orsenigo, Ludovica Riera, Mara Riminucci, Alessandro Corsi, Massimo Breccia, Alessandro Morotti, Daniela Cilloni, Aldo M Roccaro, Antonio Sacco, Fabio Stagno, Marta Serafini, Federica Mottadelli, Giovanni Cazzaniga, Fabio Pagni, Roberto Chiarle, Emanuele Azzoni, Alessandro Sessa, Carlo B Gambacorti-Passerini, Elena Maria Elli, Luca Mologni, Rocco Giovanni Piazza
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. Blood (2024)
Francesca Palandri, Elena Maria Elli, Erika Morsia, Giulia Benevolo, Mario Tiribelli, Eloise Beggiato, Massimiliano Bonifacio, Mirko Farina, Bruno Martino, Giovanni Caocci, Novella Pugliese, Alessia Tieghi, Monica Crugnola, Gianni Binotto, Francesco Cavazzini, Elisabetta Abruzzese, Alessandra Iurlo, Alessandro Isidori, Costanza Bosi, Veronica Guglielmana, Marta Venturi, Alessandra Dedola, Michele Loffredo, Gabriele Fontana, Andrea Duminuco, Alessia Moioli, Luca Tosoni, Emilia Scalzulli, Daniele Cattaneo, Roberto M Lemoli, Daniela Cilloni, Monica Bocchia, Fabrizio Pane, Florian H Heidel, Nicola Vianelli, Michele Cavo, Giuseppe A Palumbo, Filippo Branzanti, Massimo Breccia
Clinical outcomes of ruxolitinib treatment in 595 intermediate-1 risk patients with myelofibrosis: The RUX-MF Real-World Study. Cancer (2024)
Saveria Capria, Silvia Maria Trisolini, Lorenzo Torrieri, Elena Amabile, Giovanni Marsili, Alfonso Piciocchi, Walter Barberi, Anna Paola Iori, Daniela Diverio, Daniela Carmini, Massimo Breccia, Maurizio Martelli, Clara Minotti
Real-Life Management of FLT3-Mutated AML: Single-Centre Experience over 24 Years. Cancers 16 (16) (2024)
Hagop M Kantarjian, Susan Branford, Massimo Breccia, Jorge E Cortes, Fadi G Haddad, Andreas Hochhaus, Timothy Hughes, Ghayas C Issa, Elias J Jabbour, Franck E Nicolini, Koiji Sasaki, Francois Xavier-Mahon
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia? Leukemia 38 (5) (2024)
Francesca Palandri, F Branzanti, G Benevolo, E Beggiato, E Morsia, A Dedola, M Loffredo, G Fontana, G A Palumbo, Massimo Breccia, Mario Tiribelli
Ruxolitinib after fedratinib failure in patients with myelofibrosis: A real-world case series. British journal of haematology (2024)
Alessandro Laganà, Mauro Passucci, Sara Pepe, Emilia Scalzulli, Ida Carmosino, Alessandro Costa, Maria Laura Bisegna, Claudia Ielo, Maurizio Martelli, Massimo Breccia
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation. European journal of haematology 112 (6) (2024)
Hagop M Kantarjian, Susan Branford, Massimo Breccia, Jorge E Cortes, Fadi G Haddad, Andreas Hochhaus, Timothy Hughes, Ghayas C Issa, Elias J Jabbour, Franck E Nicolini, Koiji Sasaki, Francois Xavier-Mahon
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia? Leukemia (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia (2024)
Massimo Breccia
Shedding light on resistance to asciminib. Blood 144 (6) (2024)
Alessandro Costa, Elisabetta Abruzzese, Roberto Latagliata, Olga Mulas, Ida Carmosino, Emilia Scalzulli, Maria Laura Bisegna, Claudia Ielo, Maurizio Martelli, Giovanni Caocci, Massimo Breccia
Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia. Journal of clinical medicine 13 (1) (2024)
Jorge E Cortes, Koiji Sasaki, Dong-Wook Kim, Timothy P Hughes, Gabriel Etienne, Michael J Mauro, Andreas Hochhaus, Fabian Lang, Michael C Heinrich, Massimo Breccia, Michael W Deininger, Yeow Tee Goh, Jeroen J W M Janssen, Moshe Talpaz, Valle Gomez Garcia de Soria, Philipp le Coutre, Daniel J DeAngelo, Andrea Damon, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Delphine Rea
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results. Leukemia 38 (7) (2024)
Ilaria Crespiatico, Mattia Zaghi, Cristina Mastini, Deborah D'Aliberti, Mario Mauri, Carl Mirko Mercado, Diletta Fontana, Silvia Spinelli, Valentina Crippa, Elena Inzoli, Beatrice Manghisi, Ivan Civettini, Daniele Ramazzotti, Valentina Sangiorgio, Michele Gengotti, Virginia Brambilla, Andrea Aroldi, Federica Banfi, Cristiana Barone, Roberto Orsenigo, Ludovica Riera, Mara Riminucci, Alessandro Corsi, Massimo Breccia, Alessandro Morotti, Daniela Cilloni, Aldo M Roccaro, Antonio Sacco, Fabio Stagno, Marta Serafini, Federica Mottadelli, Giovanni Cazzaniga, Fabio Pagni, Roberto Chiarle, Emanuele Azzoni, Alessandro Sessa, Carlo B Gambacorti-Passerini, Elena Maria Elli, Luca Mologni, Rocco Giovanni Piazza
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. Blood 143 (14) (2024)
Hagop M Kantarjian, Susan Branford, Massimo Breccia, Jorge E Cortes, Fadi G Haddad, Andreas Hochhaus, Timothy Hughes, Ghayas C Issa, Elias J Jabbour, Franck E Nicolini, Koiji Sasaki, Francois Xavier-Mahon
Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia? Leukemia 38 (5) (2024)
C Bucelli, Isabella Capodanno, M C Miggiano, F Cavazzini, S Leonetti Crescenzi, S Russo, I Carmosino, M Annunziata, Federica Sorà, M Bonifacio, L Luciano, G Caocci, G Loglisci, C Elena, F Lunghi, R Mullai, I Attolico, G Binotto, E Crisà, Paolo Sportoletti, A Di Veroli, A R Scortechini, A P Leporace, A Maggi, M Crugnola, F Stagno, R Sancetta, P Murgano, D Rapezzi, D Luzi, D I Vincelli, S Galimberti, M Bocchia, C Fava, A Malato, Elisabetta Abruzzese, G Saglio, G Specchia, Massimo Breccia, Alessandra Iurlo, Mario Tiribelli, R Latagliata
Choice of Frontline Tyrosine-Kinase Inhibitor and Early Events in Very Elderly Patients With Chronic Myeloid Leukemia in Chronic Phase: A "Campus CML" Study. European journal of haematology (2024)
Ilaria Crespiatico, Mattia Zaghi, Cristina Mastini, Deborah D'Aliberti, Mario Mauri, Carl Mirko Mercado, Diletta Fontana, Silvia Spinelli, Valentina Crippa, Elena Inzoli, Beatrice Manghisi, Ivan Civettini, Daniele Ramazzotti, Valentina Sangiorgio, Michele Gengotti, Virginia Brambilla, Andrea Aroldi, Federica Banfi, Cristiana Barone, Roberto Orsenigo, Ludovica Riera, Mara Riminucci, Alessandro Corsi, Massimo Breccia, Alessandro Morotti, Daniela Cilloni, Aldo M Roccaro, Antonio Sacco, Fabio Stagno, Marta Serafini, Federica Mottadelli, Giovanni Cazzaniga, Fabio Pagni, Roberto Chiarle, Emanuele Azzoni, Alessandro Sessa, Carlo B Gambacorti-Passerini, Elena Maria Elli, Luca Mologni, Rocco Giovanni Piazza
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. Blood (2024)
Sílvia Marcé, Aleix Méndez, Blanca Xicoy Cirici, Natalia Estrada, Marta Cabezón, Antonella Luciana Sturla, Miriam Ratia García, Anna Angona, Paula Amat, Silvia Escribano-Serrat, Emilia Scalzulli, Mireia Morgades, Alicia Senín, Juan Carlos Carlos Hernández-Boluda, Francisca Ferrer-Marín, Eduardo Anguita, Montserrat Cortés, Esther Plensa, Massimo Breccia, J Valentín García-Gutiérrez, Lurdes Zamora, null null
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response. Journal of clinical medicine 13 (3) (2024)
Camille Kockerols, Peter J M Valk, Stephanie Dulucq, Franck-Emmanuel Nicolini, François-Xavier Mahon, Ehab Atallah, Michael J Mauro, Jerald P Radich, Simona Bernardi, Domenico Russo, Mirko Farina, Silvia Mori, Carlo B Gambacorti-Passerini, Ivan Civettini, Liu Lu, David Yeung, Susan Branford, Gioia Colafigli, Massimo Breccia, Pauline Hogenbirk, Joost van Rosmalen, Jan J Cornelissen, Peter E Westerweel
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis. American journal of hematology 99 (8) (2024)
Camille Kockerols, Peter J M Valk, Stephanie Dulucq, Franck-Emmanuel Nicolini, François-Xavier Mahon, Ehab Atallah, Michael J Mauro, Jerald P Radich, Simona Bernardi, Domenico Russo, Mirko Farina, Silvia Mori, Carlo B Gambacorti-Passerini, Ivan Civettini, Liu Lu, David Yeung, Susan Branford, Gioia Colafigli, Massimo Breccia, Pauline Hogenbirk, Joost van Rosmalen, Jan J Cornelissen, Peter E Westerweel
BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis. American journal of hematology 99 (8) (2024)
Laura Cicconi, Marialaura Bisegna, Carmelo Gurnari, David Fanciullo, Alfonso Piciocchi, Giovanni Marsili, Clara Minotti, Emilia Scalzulli, Bianca Mandelli, Luca Guarnera, Salvatore Perrone, Elettra Ortu La Barbera, Sergio Mecarocci, Annalisa Biagi, Natalia Cenfra, Andrea Corbingi, Maria Cristina Scerpa, Adriano Venditti, Maurizio Martelli, Maria Teresa Teresa Voso, Massimo Breccia, Alessandro Pulsoni
Leucocytosis during induction therapy with all-trans-retinoic acid and arsenic trioxide in acute promyelocytic leukaemia predicts differentiation syndrome and treatment-related complications. British journal of haematology (2024)
Francesca Palandri, Giuseppe A Palumbo, Giulia Benevolo, Alessandra Iurlo, Elena Maria Elli, Elisabetta Abruzzese, Nicola Polverelli, Mario Tiribelli, Giuseppe Auteri, Alessia Tieghi, Giovanni Caocci, Gianni Binotto, Francesco Cavazzini, Filippo Branzanti, Eloise Beggiato, Maurizio Miglino, Costanza Bosi, Monica Crugnola, Monica Bocchia, Bruno Martino, Novella Pugliese, Luigi Scaffidi, Marta Venturi, Andrea Duminuco, Alessandro Isidori, Daniele Cattaneo, Mauro Krampera, Fabrizio Pane, Daniela Cilloni, Gianpietro Semenzato, Roberto M Lemoli, Antonio Cuneo, Malgorzata M Trawinska, Nicola Vianelli, Michele Cavo, Massimiliano Bonifacio, Massimo Breccia
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy. Cancer (2023)
Alessandro Costa, Massimo Breccia
How to improve treatment-free remission eligibility in chronic myeloid leukaemia? British journal of haematology 204 (2) (2023)
Giovanni Iaquinta, Emilia Scalzulli, Silvia Angeloni, Ida Carmosino, Alessandro Costa, Claudia Ielo, Mauro Passucci, Chiara Masucci, Maurizio Martelli, Paola Grammatico, Massimo Breccia
CCND2 mutations in atypical chronic myeloid leukemia: a report of two cases. Leukemia & lymphoma (2023)
Carmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, Elisa Diral, Alessandro Tomelleri, Elisa Galossi, Giulia Falconi, Alessandro Bruno, Francesca Crisafulli, Micol Frassi, Chiara Cattaneo, Diego Bertoli, Massimo Bernardi, Annalisa Condorelli, Erika Morsia, Antonella Poloni, Elena Crisà, Daniela Caravelli, Paola Triggianese, Luisa Brussino, Giorgia Battipaglia, Sara Bindoli, Paolo Sfriso, Federico Caroni, Matteo Dragani, Flavia Mallegni, Federica Pilo, Davide Firinu, Antonio Curti, Cristina Papayannidis, Attilio Olivieri, Sharham Kordasti, Francesco Albano, Fabrizio Pane, Pellegrino Musto, Monica Bocchia, Elisabetta Lugli, Massimo Breccia, Marco Frigeni, Lorenzo Dagna, Raffaella Greco, Franco Franceschini, Corrado Campochiaro, Luca Cantarini, Maria Teresa Teresa Voso
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort. American journal of hematology 99 (2) (2023)
Massimo Breccia, Alfonso Piciocchi, Elisabetta Abruzzese, Daniela Cilloni, Monica Messina, Stefano Soddu, Fausto Castagnetti, Fabio Stagno, Paola Fazi, Alessandra Iurlo, Giovanni Caocci, Antonella Gozzini, Tamara Intermesoli, Mariella D'Adda, Fabrizio Pane
Italian Physicians' Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey. Journal of clinical medicine 12 (16) (2023)
Francesca Palandri, Giuseppe A Palumbo, Giulia Benevolo, Alessandra Iurlo, Elena Maria Elli, Elisabetta Abruzzese, Nicola Polverelli, Mario Tiribelli, Giuseppe Auteri, Alessia Tieghi, Giovanni Caocci, Gianni Binotto, Francesco Cavazzini, Filippo Branzanti, Eloise Beggiato, Maurizio Miglino, Costanza Bosi, Monica Crugnola, Monica Bocchia, Bruno Martino, Novella Pugliese, Luigi Scaffidi, Marta Venturi, Andrea Duminuco, Alessandro Isidori, Daniele Cattaneo, Mauro Krampera, Fabrizio Pane, Daniela Cilloni, Gianpietro Semenzato, Roberto M Lemoli, Antonio Cuneo, Malgorzata M Trawinska, Nicola Vianelli, Michele Cavo, Massimiliano Bonifacio, Massimo Breccia
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy. Cancer 130 (8) (2023)
Alessandro Costa, Massimo Breccia
How to improve treatment-free remission eligibility in chronic myeloid leukaemia? British journal of haematology (2023)
Carmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, Elisa Diral, Alessandro Tomelleri, Elisa Galossi, Giulia Falconi, Alessandro Bruno, Francesca Crisafulli, Micol Frassi, Chiara Cattaneo, Diego Bertoli, Massimo Bernardi, Annalisa Condorelli, Erika Morsia, Antonella Poloni, Elena Crisà, Daniela Caravelli, Paola Triggianese, Luisa Brussino, Giorgia Battipaglia, Sara Bindoli, Paolo Sfriso, Federico Caroni, Matteo Dragani, Flavia Mallegni, Federica Pilo, Davide Firinu, Antonio Curti, Cristina Papayannidis, Attilio Olivieri, Sharham Kordasti, Francesco Albano, Fabrizio Pane, Pellegrino Musto, Monica Bocchia, Elisabetta Lugli, Massimo Breccia, Marco Frigeni, Lorenzo Dagna, Raffaella Greco, Franco Franceschini, Corrado Campochiaro, Luca Cantarini, Maria Teresa Teresa Voso
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort. American journal of hematology 99 (2) (2023)
Fabio Efficace, Francesco Cottone, Betina Yanez, Vamsi K Kota, Fausto Castagnetti, Giovanni Caocci, Massimiliano Bonifacio, Andrea Patriarca, Isabella Capodanno, Maria Cristina Miggiano, Mario Tiribelli, Massimo Breccia, Luigia Luciano, Valentina Giai, Alessandra Iurlo, Elisabetta Abruzzese, Carmen Fava, Shira Dinner, Jessica K Altman, Gianantonio Rosti, Jorge Cortes, Marco Vignetti, David Cella
Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia. Cancer (2023)
Alessandro Costa, Massimo Breccia
How to improve treatment-free remission eligibility in chronic myeloid leukaemia? British journal of haematology 204 (2) (2023)
Carmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, Elisa Diral, Alessandro Tomelleri, Elisa Galossi, Giulia Falconi, Alessandro Bruno, Francesca Crisafulli, Micol Frassi, Chiara Cattaneo, Diego Bertoli, Massimo Bernardi, Annalisa Condorelli, Erika Morsia, Antonella Poloni, Elena Crisà, Daniela Caravelli, Paola Triggianese, Luisa Brussino, Giorgia Battipaglia, Sara Bindoli, Paolo Sfriso, Federico Caroni, Matteo Dragani, Flavia Mallegni, Federica Pilo, Davide Firinu, Antonio Curti, Cristina Papayannidis, Attilio Olivieri, Sharham Kordasti, Francesco Albano, Fabrizio Pane, Pellegrino Musto, Monica Bocchia, Elisabetta Lugli, Massimo Breccia, Marco Frigeni, Lorenzo Dagna, Raffaella Greco, Franco Franceschini, Corrado Campochiaro, Luca Cantarini, Maria Teresa Teresa Voso
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort. American journal of hematology (2023)
Francesca Palandri, Elena M Elli, Giuseppe Auteri, Massimiliano Bonifacio, Giulia Benevolo, Florian H Heidel, Simona Paglia, Malgorzata M Trawinska, Costanza Bosi, Elena Rossi, Mario Tiribelli, Alessia Tieghi, Alessandra Iurlo, Nicola Polverelli, Giovanni Caocci, Gianni Binotto, Francesco Cavazzini, Eloise Beggiato, Daniela Cilloni, Caterina Tatarelli, Francesco Mendicino, Maurizio Miglino, Monica Bocchia, Monica Crugnola, Camilla Mazzoni, Andrea D Romagnoli, Giovanni Rindone, Sara Ceglie, Alessandra D'Addio, Eleonora Santoni, Daniele Cattaneo, Daniela Bartoletti, Roberto M Lemoli, Mauro Krampera, Antonio Cuneo, Gianpietro C Semenzato, Roberto Latagliata, Elisabetta Abruzzese, Nicola Vianelli, Michele Cavo, Alessandro Andriani, Valerio De Stefano, Giuseppe Alberto Maria Palumbo, Massimo Breccia
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib. Blood cancer journal 13 (1) (2023)
Francesca Palandri, Giuseppe Alberto Maria Palumbo, Massimiliano Bonifacio, Elena Maria Elli, Mario Tiribelli, Giuseppe Auteri, Malgorzata M Trawinska, Nicola Polverelli, Giulia Benevolo, Alessia Tieghi, Fabrizio Cavalca, Giovanni Caocci, Eloise Beggiato, Gianni Binotto, Francesco Cavazzini, Maurizio Miglino, Costanza Bosi, Monica Crugnola, Monica Bocchia, Bruno Martino, Novella Pugliese, Marta Venturi, Alessandro Isidori, Daniele Cattaneo, Mauro Krampera, Fabrizio Pane, Daniela Cilloni, Gianpietro C Semenzato, Roberto M Lemoli, Antonio Cuneo, Elisabetta Abruzzese, Filippo Branzanti, Nicola Vianelli, Michele Cavo, Florian H Heidel, Alessandra Iurlo, Massimo Breccia
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis. Cancers 15 (20) (2023)
Francesca Palandri, Elena M Elli, Giuseppe Auteri, Massimiliano Bonifacio, Giulia Benevolo, Florian H Heidel, Simona Paglia, Malgorzata M Trawinska, Costanza Bosi, Elena Rossi, Mario Tiribelli, Alessia Tieghi, Alessandra Iurlo, Nicola Polverelli, Giovanni Caocci, Gianni Binotto, Francesco Cavazzini, Eloise Beggiato, Daniela Cilloni, Caterina Tatarelli, Francesco Mendicino, Maurizio Miglino, Monica Bocchia, Monica Crugnola, Camilla Mazzoni, Andrea D Romagnoli, Giovanni Rindone, Sara Ceglie, Alessandra D'Addio, Eleonora Santoni, Daniele Cattaneo, Daniela Bartoletti, Roberto M Lemoli, Mauro Krampera, Antonio Cuneo, Gianpietro C Semenzato, Roberto Latagliata, Elisabetta Abruzzese, Nicola Vianelli, Michele Cavo, Alessandro Andriani, Valerio De Stefano, Giuseppe Alberto Maria Palumbo, Massimo Breccia
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib. Blood cancer journal 13 (1) (2023)
Carmelo Gurnari, Maria Rosaria Pascale, Antonio Vitale, Elisa Diral, Alessandro Tomelleri, Elisa Galossi, Giulia Falconi, Alessandro Bruno, Francesca Crisafulli, Micol Frassi, Chiara Cattaneo, Diego Bertoli, Massimo Bernardi, Annalisa Condorelli, Erika Morsia, Antonella Poloni, Elena Crisà, Daniela Caravelli, Paola Triggianese, Luisa Brussino, Giorgia Battipaglia, Sara Bindoli, Paolo Sfriso, Federico Caroni, Matteo Dragani, Flavia Mallegni, Federica Pilo, Davide Firinu, Antonio Curti, Cristina Papayannidis, Attilio Olivieri, Sharham Kordasti, Francesco Albano, Fabrizio Pane, Pellegrino Musto, Monica Bocchia, Elisabetta Lugli, Massimo Breccia, Marco Frigeni, Lorenzo Dagna, Raffaella Greco, Franco Franceschini, Corrado Campochiaro, Luca Cantarini, Maria Teresa Teresa Voso
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort. American journal of hematology 99 (2) (2023)
Alessandro Costa, Massimo Breccia
How to improve treatment-free remission eligibility in chronic myeloid leukaemia? British journal of haematology 204 (2) (2023)
Massimo Breccia, Pier Paolo Olimpieri, Simone Celant, Odoardo Maria Olimpieri, Fabrizio Pane, Alessandra Iurlo, Valentina Summa, Paolo Corradini, Pierluigi Russo
Effectiveness and management of ponatinib as second-line treatment in chronic myeloid leukemia: an analysis from the monitoring registries of the Italian medicines agency (AIFA). Annals of hematology (2023)
Francesca Palandri, Elena M Elli, Giuseppe Auteri, Massimiliano Bonifacio, Giulia Benevolo, Florian H Heidel, Simona Paglia, Malgorzata M Trawinska, Costanza Bosi, Elena Rossi, Mario Tiribelli, Alessia Tieghi, Alessandra Iurlo, Nicola Polverelli, Giovanni Caocci, Gianni Binotto, Francesco Cavazzini, Eloise Beggiato, Daniela Cilloni, Caterina Tatarelli, Francesco Mendicino, Maurizio Miglino, Monica Bocchia, Monica Crugnola, Camilla Mazzoni, Andrea D Romagnoli, Giovanni Rindone, Sara Ceglie, Alessandra D'Addio, Eleonora Santoni, Daniele Cattaneo, Daniela Bartoletti, Roberto M Lemoli, Mauro Krampera, Antonio Cuneo, Gianpietro C Semenzato, Roberto Latagliata, Elisabetta Abruzzese, Nicola Vianelli, Michele Cavo, Alessandro Andriani, Valerio De Stefano, Giuseppe Alberto Maria Palumbo, Massimo Breccia
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib. Blood cancer journal 13 (1) (2023)
Massimo Breccia
A traffic light for TFR by lineage-specific MRD. Blood 142 (25) (2023)
Alessandro Costa, Ida Carmosino, Emilia Scalzulli, Clara Minotti, Maria Stefania De Propris, Chiara Masucci, Mauro Passucci, Maria Laura Bisegna, Claudia Ielo, Sara Pepe, Daniela Diverio, Maurizio Martelli, Massimo Breccia
Early death risk score in acute promyelocytic leukemia: A retrospective analysis from a monocentric cohort. European journal of haematology (2023)
Alessandro Costa, Emilia Scalzulli, Ida Carmosino, Marcello Capriata, Claudia Ielo, Chiara Masucci, Mauro Passucci, Maurizio Martelli, Massimo Breccia
Systemic mastocytosis: 2023 update on diagnosis and management in adults. Expert opinion on emerging drugs (2023)
Francesca Palandri, Giuseppe A Palumbo, Giulia Benevolo, Alessandra Iurlo, Elena Maria Elli, Elisabetta Abruzzese, Nicola Polverelli, Mario Tiribelli, Giuseppe Auteri, Alessia Tieghi, Giovanni Caocci, Gianni Binotto, Francesco Cavazzini, Filippo Branzanti, Eloise Beggiato, Maurizio Miglino, Costanza Bosi, Monica Crugnola, Monica Bocchia, Bruno Martino, Novella Pugliese, Luigi Scaffidi, Marta Venturi, Andrea Duminuco, Alessandro Isidori, Daniele Cattaneo, Mauro Krampera, Fabrizio Pane, Daniela Cilloni, Gianpietro Semenzato, Roberto M Lemoli, Antonio Cuneo, Malgorzata M Trawinska, Nicola Vianelli, Michele Cavo, Massimiliano Bonifacio, Massimo Breccia
Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy. Cancer 130 (8) (2023)
Mario Tiribelli, Roberto Latagliata, Massimo Breccia, Isabella Capodanno, Maria Cristina Miggiano, Francesco Cavazzini, Cristina Bucelli, Immacolata Attolico, Sabrina Leonetti Crescenzi, Sabina Russo, Mario Annunziata, Federica Sorà, Massimiliano Bonifacio, Olga Mulas, Giuseppina Loglisci, Alessandro Maggi, Gianni Binotto, Elena Crisà, Anna Rita Scortechini, Anna Paola Leporace, Rosaria Sancetta, Pamela Murgano, Elisabetta Abruzzese, Fabio Stagno, Davide Rapezzi, Debora Luzi, Iolanda Vincelli, Monica Bocchia, Carmen Fava, Alessandra Malato, Monica Crugnola, Michele Pizzuti, Francesca Lunghi, Sara Galimberti, Matteo Dalmazzo, Renato Fanin, Emilia Scalzulli, Robin Foà, Alessandra Iurlo, Giuseppe Saglio, Giorgina Specchia
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML. Cancer (2023)
Massimo Breccia
A traffic light for TFR by lineage-specific MRD. Blood 142 (25) (2023)
Massimo Breccia, Giuseppe Saglio
Interferon in chronic myeloid leukaemia: Is it useful for treatment-free remission? British journal of haematology (2023)
Alessandro Laganà, Sara Pepe, Emilia Scalzulli, Ida Carmosino, Mauro Passucci, Claudia Ielo, Alessandro Costa, Chiara Masucci, Daniela Diverio, Maurizio Martelli, Massimo Breccia
One-month qRT-PCR BCR::ABL1 transcript threshold to predict early recurrence in chronic phase CML patients attempting first treatment free remission. European journal of haematology (2023)
Francesca Palandri, Elena M Elli, Giuseppe Auteri, Massimiliano Bonifacio, Giulia Benevolo, Florian H Heidel, Simona Paglia, Malgorzata M Trawinska, Costanza Bosi, Elena Rossi, Mario Tiribelli, Alessia Tieghi, Alessandra Iurlo, Nicola Polverelli, Giovanni Caocci, Gianni Binotto, Francesco Cavazzini, Eloise Beggiato, Daniela Cilloni, Caterina Tatarelli, Francesco Mendicino, Maurizio Miglino, Monica Bocchia, Monica Crugnola, Camilla Mazzoni, Andrea D Romagnoli, Giovanni Rindone, Sara Ceglie, Alessandra D'Addio, Eleonora Santoni, Daniele Cattaneo, Daniela Bartoletti, Roberto M Lemoli, Mauro Krampera, Antonio Cuneo, Gianpietro C Semenzato, Roberto Latagliata, Elisabetta Abruzzese, Nicola Vianelli, Michele Cavo, Alessandro Andriani, Valerio De Stefano, Giuseppe Alberto Maria Palumbo, Massimo Breccia
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib. Blood cancer journal 13 (1) (2023)
Luca Lanino, Francesco Restuccia, Alessandra Perego, Marta Ubezio, Bruno Fattizzo, Marta Riva, Angela Consagra, Pellegrino Musto, Daniela Cilloni, Esther Natalie Oliva, Raffaele Palmieri, Antonella Poloni, Catello Califano, Isabella Capodanno, Federico Itri, Chiara Elena, Claudio Fozza, Fabrizio Pane, Anna Maria Pelizzari, Massimo Breccia, Francesco Di Bassiano, Elena Crisà, Dario Ferrero, Valentina Giai, Daniela Barraco, Antonella Vaccarino, Davide Griguolo, Paola Minetto, Martina Quintini, Stefania Paolini, Grazia Sanpaolo, Mariarosaria Sessa, Monica Bocchia, Nicola Di Renzo, Elisa Diral, Livia Leuzzi, Angelo Genua, Attilio Guarini, Alfredo Molteni, Barbara Nicolino, Ubaldo Occhini, Giulia Rivoli, Roberto Bono, Anna Calvisi, Andrea Castelli, Eros Di Bona, Ambra Di Veroli, Felicetto Ferrara, Luana Fianchi, Sara Galimberti, Daniele Grimaldi, Monia Marchetti, Marianna Norata, Marco Frigeni, Rosaria Sancetta, Carmine Selleri, Ilaria Tanasi, Patrizia Tosi, Mauro Turrini, Laura Giordano, Carlo Finelli, Paolo Pasini, Ilaria Naldi, Valeria Santini, Matteo Giovanni Della Porta, null null
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts. American journal of hematology (2023)
Francesca Palandri, Elena Rossi, Giuseppe Auteri, Massimo Breccia, Simona Paglia, Giulia Benevolo, Elena Maria Elli, Francesco Cavazzini, Gianni Binotto, Alessia Tieghi, Mario Tiribelli, Florian H Heidel, Massimiliano Bonifacio, Novella Pugliese, Giovanni Caocci, Monica Crugnola, Francesco Mendicino, Alessandra D'Addio, Simona Tomassetti, Bruno Martino, Nicola Polverelli, Sara Ceglie, Camilla Mazzoni, Rikard Mullai, Alessia Ripamonti, Bruno Garibaldi, Fabrizio Pane, Antonio Cuneo, Mauro Krampera, Gianpietro Semenzato, Roberto M Lemoli, Nicola Vianelli, Giuseppe Alberto Maria Palumbo, Alessandro Andriani, Michele Cavo, Roberto Latagliata, Valerio De Stefano
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study. Cancers 15 (14) (2023)
Francesca Palandri, Massimo Breccia, Camilla Mazzoni, Giuseppe Auteri, Elena Maria Elli, Malgorzata M Trawinska, Nicola Polverelli, Mario Tiribelli, Giulia Benevolo, Alessandra Iurlo, Alessia Tieghi, Florian H Heidel, Giovanni Caocci, Eloise Beggiato, Gianni Binotto, Francesco Cavazzini, Maurizio Miglino, Costanza Bosi, Monica Crugnola, Monica Bocchia, Bruno Martino, Novella Pugliese, Mattia Biondo, Marta Venturi, Luigi Scaffidi, Alessandro Isidori, Daniele Cattaneo, Mauro Krampera, Fabrizio Pane, Daniela Cilloni, Gianpietro Semenzato, Roberto M Lemoli, Antonio Cuneo, Elisabetta Abruzzese, Daniela Bartoletti, Simona Paglia, Nicola Vianelli, Michele Cavo, Massimiliano Bonifacio, Giuseppe A Palumbo
Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome. Cancer (2023)
Michael J Mauro, Timothy P Hughes, Dong-Wook Kim, Delphine Rea, Jorge E Cortes, Andreas Hochhaus, Koiji Sasaki, Massimo Breccia, Moshe Talpaz, Oliver Ottmann, Hironobu Minami, Yeow Tee Goh, Daniel J DeAngelo, Michael C Heinrich, Valle Gómez-García de Soria, Philipp le Coutre, Francois-Xavier Mahon, Jeroen J W M Janssen, Michael Deininger, Naranie Shanmuganathan, Mark Blaine Geyer, Silvia Cacciatore, Fotis Polydoros, Nithya Agrawal, Matthias Hoch, Fabian Lang
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results. Leukemia (2023)
Massimo Breccia
A traffic light for TFR by lineage-specific MRD. Blood 142 (25) (2023)
Emilia Scalzulli, Claudia Ielo, Cristina Luise, Paolo Musiu, Maria L Bisegna, Ida Carmosino, Giovanni Manfredi Assanto, Maurizio Martelli, Massimo Breccia
RR6 prognostic model provides information about survival for myelofibrosis treated with ruxolitinib: validation in a real-life cohort. Blood advances 6 (15) (2022)
Mohammad Houshmand, Nicoletta Vitale, Francesca Orso, Alessandro Cignetti, Ivan Molineris, Valentina Gaidano, Stefano Sainas, Marta Giorgis, Donatella Boschi, Carmen Fava, Alice Passoni, Marta Gai, Massimo Geuna, Federica Sora, Alessandra Iurlo, Elisabetta Abruzzese, Massimo Breccia, Olga Mulas, Giovanni Caocci, Fausto Castagnetti, Daniela Taverna, Salvatore Oliviero, Fabrizio Pane, Marco Lucio Lolli, Paola Circosta, Giuseppe Saglio
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia. Cell death & disease 13 (6) (2022)
Elena Maria Elli, Ambra Di Veroli, Daniela Bartoletti, Alessandra Iurlo, Ida Carmosino, Giulia Benevolo, Elisabetta Abruzzese, Massimiliano Bonifacio, Micaela Bergamaschi, Nicola Polverelli, Marianna Caramella, Daniela Cilloni, Mario Tiribelli, Novella Pugliese, Giovanni Caocci, Elena Crisà, Raffaele Porrini, Uros Markovic, Rossella Renso, Giuseppe Auteri, Daniele Cattaneo, Malgorzata Monika Trawinska, Luigi Scaffidi, Lucia Biale, Cristina Bucelli, Massimo Breccia, Carlo Gambacorti-Passerini, Giuseppe Alberto Palumbo, Roberto Latagliata, Francesca Palandri
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study. British journal of haematology 197 (2) (2022)
Massimo Breccia, Luca Petriccione, Caterina Tatarelli, Marianna De Muro, Malgorzata Monica Trawinska, Michelina Santopietro, Antonio Spadea, Ambra Di Veroli, Emilia Scalzulli, Katia Paciaroni, Agostino Tafuri, Roberto Latagliata, Alessandro Andriani, Arianna Di Napoli
Sequential occurrence of chronic myeloproliferative and lymphoproliferative neoplasms: a collaborative retrospective study by pH-negative MPN latial group. Leukemia & lymphoma 63 (11) (2022)
Massimo Breccia, A Piciocchi, Monica Messina, S Soddu, V De Stefano, M Bellini, A Iurlo, B Martino, S Siragusa, F Albano, B Mora, P Fazi, M Vignetti, Paola Guglielmelli, Francesca Palandri
Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine. Leukemia 36 (10) (2022)
Francesca Palandri, Daniela Bartoletti, Alessandra Iurlo, Massimiliano Bonifacio, Elisabetta Abruzzese, Giovanni Caocci, Elena M Elli, Giuseppe Auteri, Mario Tiribelli, Nicola Polverelli, Maurizio Miglino, Florian H Heidel, Alessia Tieghi, Giulia Benevolo, Eloise Beggiato, Carmen Fava, Francesco Cavazzini, Novella Pugliese, Gianni Binotto, Costanza Bosi, Bruno Martino, Monica Crugnola, Emanuela Ottaviani, Giorgia Micucci, Malgorzata M Trawinska, Antonio Cuneo, Monica Bocchia, Mauro Krampera, Fabrizio Pane, Roberto M Lemoli, Daniela Cilloni, Nicola Vianelli, Michele Cavo, Giuseppe A Palumbo, Massimo Breccia
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis. Cancer 128 (13) (2022)
Maria Cristina Puzzolo, Massimo Breccia, Paola Mariglia, Gioia Colafigli, Sara Pepe, Emilia Scalzulli, Elena Mariggiò, Roberto Latagliata, Anna Guarini, Robin Foà
Immunomodulatory Effects of IFNα on T and NK Cells in Chronic Myeloid Leukemia Patients in Deep Molecular Response Preparing for Treatment Discontinuation. Journal of clinical medicine 11 (19) (2022)
Massimo Breccia, Francesca Chiodi, Aurelio Pio Nardozza, Diletta Valsecchi, Valentina Perrone, Diego Sangiorgi, Elisa Giacomini, Maria Chiara Rendace, Paola Coco, Eleonora Premoli, Luca Degli Esposti
Real-World Analysis of the Therapeutic Management and Disease Burden in Chronic Myeloid Leukemia Patients with Later Lines in Italy. Journal of clinical medicine 11 (13) (2022)
Sara Pepe, Elena Rossi, Malgorzata Trawinska, Caterina Tatarelli, Ambra Di Veroli, Luca Maurillo, Atelda Romano, Sabrina Leonetti Crescenzi, Tommaso Caravita di Toritto, Agostino Tafuri, Roberto Latagliata, Emilia Scalzulli, Alessandro Andriani, Valerio De Stefano, Massimo Breccia
Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group. Annals of hematology 101 (6) (2022)
Matteo Molica, Carla Mazzone, Pasquale Niscola, Ida Carmosino, Ambra Di Veroli, Cinzia De Gregoris, Fabrizio Bonanni, Salvatore Perrone, Natalia Cenfra, Luana Fianchi, Anna Lina Piccioni, Antonio Spadea, Giovanni Luzi, Andrea Mengarelli, Laura Cudillo, Luca Maurillo, Livio Pagano, Massimo Breccia, Luigi Rigacci, Paolo De Fabritiis
Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience. Cancers 14 (19) (2022)
Roberta Soscia, Irene Della Starza, Lucia Anna De Novi, Caterina Ilari, Michela Ansuinelli, Marzia Cavalli, Vittorio Bellomarino, Luciana Cafforio, Mariangela Di Trani, Giovanni Cazzaniga, Grazia Fazio, Alessandra Santoro, Domenico Salemi, Orietta Spinelli, Manuela Tosi, Carolina Terragna, Valentina Robustelli, Teresa Bellissimo, Gioia Colafigli, Massimo Breccia, Sabina Chiaretti, Alice Di Rocco, Maurizio Martelli, Anna Guarini, Ilaria Del Giudice, Robin Foà
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biases. Hematological oncology (2022)
Giovanni Manfredi Assanto, Emilia Scalzulli, Ida Carmosino, Maurizio Martelli, Massimo Breccia
From bench to bedside: bridging the gaps in best practices for real-world chronic myeloid leukemia care. Expert review of hematology 15 (11) (2022)
Massimo Breccia, Francesca Palandri, Paola Guglielmelli, Giuseppe Alberto Maria Palumbo, Alessandra Malato, Francesco Mendicino, Alessandra Ricco, Emanuela Sant'Antonio, Mario Tiribelli, Alessandra Iurlo
Management of Myelofibrosis during Treatment with Ruxolitinib: A Real-World Perspective in Case of Resistance and/or Intolerance. Current oncology (Toronto, Ont.) 29 (7) (2022)
Carmelo Gurnari, Alfonso Piciocchi, Stefano Soddu, Fabrizio Bonanni, Emilia Scalzulli, Pasquale Niscola, Ambra Di Veroli, Anna Lina Piccioni, Monica Piedimonte, Gianluca Maiorana, Prassede Salutari, Laura Cicconi, Michelina Santopietro, Svitlana Gumenyuk, Chiara Sarlo, Susanna Fenu, Agostino Tafuri, Roberto Latagliata, Luana Fianchi, Marianna Criscuolo, Jaroslaw P Maciejewski, Luca Maurillo, Francesco Buccisano, Massimo Breccia, Maria Teresa Teresa Voso
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide. Blood cancer journal 12 (9) (2022)
Massimo Breccia, Pier Paolo Olimpieri, Simone Celant, Odoardo Olimpieri, Fabrizio Pane, Alessandra Iurlo, Valentina Summa, Paolo Corradini, Pierluigi Russo
Management of chronic myeloid leukaemia patients treated with ponatinib in a real-life setting: A retrospective analysis from the monitoring registries of the Italian Medicines Agency (AIFA). British journal of haematology 198 (6) (2022)
Emilia Scalzulli, Ida Carmosino, Maria Laura Bisegna, Maurizio Martelli, Massimo Breccia
CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New Directions. Current hematologic malignancy reports 17 (6) (2022)
Giuseppe Alberto Maria Palumbo, Massimo Breccia, Claudia Baratè, Massimiliano Bonifacio, Elena Maria Elli, Alessandra Iurlo, Novella Pugliese, Elena Rossi, Paola Guglielmelli, Francesca Palandri
Management of polycythemia vera: A survey of treatment patterns in Italy. European journal of haematology (2022)
Alessia Campagna, Daniela De Benedittis, Luana Fianchi, Emilia Scalzulli, Lorenzo Rizzo, Pasquale Niscola, Anna Lina Piccioni, Ambra Di Veroli, Stefano Mancini, Nicoletta Villivà, Tiziano Martini, Sara Mohamed, Ida Carmosino, Marianna Criscuolo, Susanna Fenu, Maria Antonietta Aloe Spiriti, Francesco Buccisano, Marco Mancini, Agostino Tafuri, Massimo Breccia, Antonella Poloni, Roberto Latagliata
Myelodysplastic Syndromes with Isolated 20q Deletion: A New Clinical-Biological Entity? Journal of clinical medicine 11 (9) (2022)
Alessandro Laganà, Emilia Scalzulli, Ida Carmosino, Maurizio Martelli, Massimo Breccia
Asciminib as a third line option in chronic myeloid leukemia. International journal of hematology (2022)
Francesca Fazio, Martina Quintini, Ida Carmosino, Caterina Matteucci, Eleonora Miulli, Fabrizia Pellanera, Benedetta Lucani, Michela Ansuinelli, Massimo Breccia, Cristina Mecucci, Roberto Latagliata
New dead/H-box helicase gene (ddx41) mutation in an Italian family with recurrent leukemia. Leukemia & lymphoma 62 (9) (2021)
Francesca Palandri, Giuseppe Alberto Maria Palumbo, Elena Maria Elli, Nicola Polverelli, Giulia Benevolo, Bruno Martino, Elisabetta Abruzzese, Mario Tiribelli, Alessia Tieghi, Roberto Latagliata, Francesco Cavazzini, Micaela Bergamaschi, Gianni Binotto, Monica Crugnola, Alessandro Isidori, Giovanni Caocci, Florian H Heidel, Novella Pugliese, Costanza Bosi, Daniela Bartoletti, Giuseppe Auteri, Daniele Cattaneo, Luigi Scaffidi, Malgorzata Monica Trawinska, Rossella Stella, Fiorella Ciantia, Fabrizio Pane, Antonio Cuneo, Mauro Krampera, Gianpietro C Semenzato, Roberto Massimo Lemoli, Alessandra Iurlo, Nicola Vianelli, Michele Cavo, Massimo Breccia, Massimiliano Bonifacio
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis. Blood cancer journal 11 (1) (2021)
Roberto Latagliata, Immacolata Attolico, Malgorzata Monika Trawinska, Isabella Capodanno, Mario Annunziata, Chiara Elena, Luigiana Luciano, Monica Crugnola, Micaela Bergamaschi, Massimiliano Bonifacio, Claudia Baratè, Endri Mauro, Gianni Binotto, Nicola Sgherza, Chiara Aguzzi, Barbara Monteleone, Federica Sorà, Giovanni Caocci, Debora Luzi, Elena Mariggiò, Luigi Scaffidi, Daniele Cattaneo, Antonella Gozzini, Ambra Di Veroli, Elisabetta Abruzzese, Sara Galimberti, Alessandra Iurlo, Giorgina Specchia, Massimo Breccia
Bosutinib in the real-life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine-kinase inhibitors. Hematological oncology 39 (3) (2021)
Fabio Efficace, Laura Cannella, Massimo Breccia, Jacopo Olivieri, Uwe Platzbecker, Marco Vignetti
Health-related quality of life in patients with acute promyelocytic leukemia: a systematic literature review. Expert review of hematology 14 (7) (2021)
Paola Guglielmelli, Francesca Palandri, Carmine Selleri, Daniela Cilloni, Francesco Mendicino, Patrizio Mazza, Domenico Pastore, Giuseppe A Palumbo, Marco Santoro, Vincenzo Pavone, Stefana Impera, Mara Morelli, Paola Coco, Diletta Valsecchi, Francesco Passamonti, Massimo Breccia, null null
Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI). Leukemia & lymphoma (2021)
Massimo Breccia, Patrizia Pregno, Fausto Castagnetti, Massimiliano Bonifacio, Mario Tiribelli, Antonella Gozzini, Anna Rita Scortechini, Luigiana Luciano, Bruno Martino, Fabio Stagno, Giovanni Caocci, Gaetano La Barba, Michele Pizzuti, Giovannino Ciccone, Giuseppe Saglio, Giorgina Specchia
Eutos long-term survival score discriminates different Sokal score categories in chronic myeloid leukemia patients, showing better survival prediction. Analysis of the GIMEMA CML observational study. Leukemia 35 (6) (2021)
Massimo Breccia, Simone Celant, Pier Paolo Olimpieri, Odoardo M Olimpieri, Fabrizio Pane, Alessandra Iurlo, Alessia Cirilli, Antonietta Colatrella, Lucia Gozzo, Sara Pugliese, Valentina Summa, Paolo Foggi, Paolo Corradini, Pierluigi Russo, null null
Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA). Annals of hematology 100 (2) (2021)
Fabio Efficace, Massimo Breccia, Paola Fazi, Francesco Cottone, Bernhard Holzner, Marco Vignetti
The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study. JMIR research protocols 10 (6) (2021)
Massimo Breccia, Emilia Scalzulli, Sara Pepe, Gioia Colafigli, Maria Laura Bisegna, Marcello Capriata, Maurizio Martelli
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients. Expert review of hematology 15 (1) (2021)
Massimo Breccia, Elisabetta Abruzzese, Vincenzo Accurso, Immacolata Attolico, Sara Barulli, Micaela Bergamaschi, Gianni Binotto, Monica Bocchia, Massimiliano Bonifacio, Giovanni Caocci, Isabella Capodanno, Fausto Castagnetti, Francesco Cavazzini, Elena Crisà, Monica Crugnola, Maria Stella De Candia, Chiara Elena, Carmen Fava, Sara Galimberti, Antonella Gozzini, Gabriele Gugliotta, Tamara Intermesoli, Alessandra Iurlo, Gaetano La Barba, Roberto Latagliata, Sabrina Leonetti Crescenzi, Luciano Levato, Giuseppina Loglisci, Alessandro Lucchesi, Luigiana Luciano, Francesca Lunghi, Debora Luzi, Alessandra Malato, Maria Cristina Miggiano, Michele Pizzuti, Patrizia Pregno, Davide Rapezzi, Giovanna Rege-Cambrin, Gianantonio Rosti, Sabina Russo, Rosaria Sancetta, Anna Rita Scortechini, Federica Sorà, Paolo Sportoletti, Fabio Stagno, Agostino Tafuri, Mario Tiribelli, Robin Foà, Giuseppe Saglio
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report. British journal of haematology (2021)
Sara Pepe, Emilia Scalzulli, Gioia Colafigli, Alessio Di Prima, Marco Mancini, Daniela Diverio, Roberto Latagliata, Maurizio Martelli, Robin Foà, Massimo Breccia
Long-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure: a single center experience. Leukemia & lymphoma 62 (9) (2021)
Serena Rosati, Carmelo Gurnari, Massimo Breccia, Ida Carmosino, Emilia Scalzulli, Enrico Montefusco, Salvatore Perrone, Ombretta Annibali, Vincenza Martini, Giulio Trapè, Gioia Colafigli, Malgorzata Trawinska, Clara Minotti, Giuseppe Cimino, Agostino Tafuri, Giuseppe Avvisati, Maurizio Martelli, Maria Teresa Voso, Roberto Latagliata
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols. Acta oncologica (Stockholm, Sweden) 60 (11) (2021)
Massimo Breccia, Fabio Efficace, Emilia Scalzulli, Giulia Ciotti, Giacomo Maestrini, Gioia Colafigli, Maurizio Martelli
Measuring prognosis in chronic myeloid leukemia: what's new? Expert review of hematology 14 (6) (2021)
Giulia Benevolo, Elena M Elli, Daniela Bartoletti, Roberto Latagliata, Mario Tiribelli, Florian H Heidel, Francesco Cavazzini, Massimiliano Bonifacio, Monica Crugnola, Gianni Binotto, Alessandra D'Addio, Alessia Tieghi, Micaela Bergamaschi, Giovanni Caocci, Nicola Polverelli, Elisa Bossi, Giuseppe Auteri, Ida Carmosino, Lucia Catani, Antonio Cuneo, Mauro Krampera, Francesco Lanza, Roberto M Lemoli, Nicola Vianelli, Massimo Breccia, Giuseppe A Palumbo, Michele Cavo, Francesca Palandri
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients. Hematological oncology 39 (3) (2021)
Francesca Palandri, Massimo Breccia, Valerio De Stefano, Francesco Passamonti
Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future Scenarios. Cancers 13 (19) (2021)
Fabio Efficace, Uwe Platzbecker, Massimo Breccia, Francesco Cottone, Paola Carluccio, Prassede Salutari, Eros Di Bona, Erika Borlenghi, Francesco Autore, Luciano Levato, Olimpia Finizio, Valentina Mancini, Stefano D'Ardia, Richard F Schlenk, Lorella Melillo, Monica Fumagalli, Walter Fiedler, Germana Beltrami, Nicola Stefano Fracchiolla, Bernardi Massimo, Paola Fazi, Ombretta Annibali, Karin Mayer, Maria Teresa Teresa Voso, Marco Vignetti
Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy. Blood advances 5 (21) (2021)
Francesca Palandri, Mario Tiribelli, Massimo Breccia, Daniela Bartoletti, Elena M Elli, Giulia Benevolo, Bruno Martino, Francesco Cavazzini, Alessia Tieghi, Alessandra Iurlo, Elisabetta Abruzzese, Novella Pugliese, Gianni Binotto, Giovanni Caocci, Giuseppe Auteri, Daniele Cattaneo, Malgorzata M Trawinska, Rossella Stella, Luigi Scaffidi, Nicola Polverelli, Giorgia Micucci, Elena Masselli, Monica Crugnola, Costanza Bosi, Florian H Heidel, Roberto Latagliata, Fabrizio Pane, Antonio Cuneo, Mauro Krampera, Gianpietro Semenzato, Roberto M Lemoli, Michele Cavo, Nicola Vianelli, Massimiliano Bonifacio, Giuseppe Alberto Maria Palumbo
Ruxolitinib rechallenge in resistant or intolerant patients with myelofibrosis: Frequency, therapeutic effects, and impact on outcome. Cancer 127 (15) (2021)
Fabio Stagno, Massimo Breccia, Mario Annunziata, Malgorzata Monika Trawinska, Alessandra Iurlo, Nicola Sgherza, Carmen Fava, Antonella Gozzini, Luigiana Luciano, Ida Carmosino, Massimiliano Bonifacio, Federica Sorà, Sabrina Leonetti Crescenzi, Monica Crugnola, Gabriele Gugliotta, Sara Galimberti, Cristina Bucelli, Gioia Colafigli, Costanzo Feo, Mario Tiribelli, Endri Mauro, Antonella Russo Rossi, Attilio Guarini, Elisabetta Abruzzese, Gianantonio Rosti, Francesco Di Raimondo, Roberto Latagliata
Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials: a real-life cohort observational study. Acta oncologica (Stockholm, Sweden) 60 (11) (2021)
Emilia Scalzulli, Giovanni Caocci, Fabio Efficace, Lorenzo Rizzo, Gioia Colafigli, Alessio Di Prima, Sara Pepe, Danilo Alunni Fegatelli, Ida Carmosino, Daniela Diverio, Roberto Latagliata, Giorgio La Nasa, Maurizio Martelli, Robin Foà, Massimo Breccia
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients. Annals of hematology 100 (5) (2021)
Massimo Breccia, Gioia Colafigli, Emilia Scalzulli, Maurizio Martelli
Asciminib: an investigational agent for the treatment of chronic myeloid leukemia. Expert opinion on investigational drugs 30 (8) (2021)
Fabio Efficace, Marco Vignetti, Francesco Sparano, Emilia Scalzulli, Massimo Breccia
Optimizing health-related quality of life in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. Expert review of hematology 14 (3) (2021)

Massimo Breccia.css-eqlu8i{font-size:small;padding-left:4px;} (M Breccia)

Publication Activity (10 Years)

Top Topics

Top Venues

Massimo Breccia (M Breccia)